Wen Hsieh (Greentech, China, Digital)


Wen Hsieh joined Kleiner Perkins Caufield & Byers in early 2006. He focuses on incubations and early-stage investments in disruptive Digital hardware (consumer/enterprise) and semiconductor innovations, as well as Green technologies. Wen also leads KPCB’s Low Power Everywhere initiative. He works closely with the entrepreneurs at Amprius, Aquion Energy, Bloom Energy, Crossbar, HiWiFi, LuxVue, mCube, SuVolta, TiDAL Systems, Transphorm and Voltafield as a board director/observer or advisor. Wen advocated KPCB’s early investment in Amyris Biotechnologies (Nasdaq: AMRS), and as a board observer, he supported Amyris from Series A through IPO.

Before joining KPCB, Wen was an Associate Principal at McKinsey & Company San Francisco and a leader of McKinsey’s Asia semiconductor practice. During his five years at McKinsey, Wen focused primarily on serving leading companies across the global semiconductor value chain. His clients included EDA companies, IC design houses, wafer fab equipment vendors, automated test equipment suppliers, test solution providers, wafer foundries, logic and memory IDMs, PC and server OEMs and electronic component distributors. His secondary focus at McKinsey was on the North America biopharma sector, where his clients were small companies in the anti-viral, generics and specialty pharma segments.
Earlier in his career, Wen founded OnChip Technologies, a startup developing MEMS microfluidic biochips. The company’s target market was high-sensitivity and high-throughput peptide separation and identification applications.

Wen earned a Ph.D. in electrical engineering and a Ph.D. minor in biology from the California Institute of Technology. He also received a B.S. degree with honors and an M.S. degree in electrical engineering from the same institution.



Public / Acquired / Merged